Prognostic significance of ischemia-modified albumin in acute ischemic stroke patients: A preliminary study

Annals of Neurosciences

Volumn 18, Issue 1, 2011, Pages 5-7

  Nayak, Amit R ^a   Kashyap, Rajpal S ^a   Kabra, Dinesh ^a   Purohit, Hemant J ^b   Taori, Girdhar M ^a   Daginawala, Hatim F ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^b NATIONAL ENVIRONMENTAL ENGINEERING RESEARCH INSTITUTE   (India)

Author keywords

Acute ischemic stroke prognosis ischemia modified albumin biomarker serum marker

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; ISCHEMIA MODIFIED ALBUMIN;

ACUTE ISCHEMIC STROKE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INDIA; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN BLOOD LEVEL; STROKE PATIENT;

EID: 79960140952     PISSN: 09727531     EISSN: 09763260     Source Type: Journal    
DOI: 10.5214/ans.0972.7531.1118103     Document Type: Article

References (11)

1. Banerjee TK and Das SK. Epidemiology of stroke in India. Neurology Asia 2006; 11: 1-4.
2. Stringer KA. Clinical trials in thrombolytic therapy, Part 1: Outcome markers that go beyond mortality reduction. Am J Health Syst Pharm 1997; 54(1): S23-S26.
3. Kashyap RS, Kabra DP, Nayak AR, et al. Protein electrophoretogram in serum of acute ischemic stroke patients and its correlation with S-100ß and neuron specific enolase level: A pilot study. Annals of Neurosciences 2006; 13(2): 36-40.
4. Cuzzocrea S, Riley DP, Caputi AP, et al. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53: 135-159.
5. Roy D, Quiles J, Gaze DC, et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006; 92 (1): 113-114.
6. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia: a preliminary report. J Emerg Med 2000; 19 (4): 311-315.
7. Refaai MA, Wright RW, Parvin CA, et al. Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery. Clin Chim Acta 2006; 366 (1-2): 264-268.
8. Gunduz A, Turedi S, Mentese A, et al. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008; 26(8): 874-878.
9. Sundt TM, Waltz AG, Sayre GP. Experimental cerebral infarction: modification by treatment with hemodiluting, hemoconcentrating, and dehydrating agents. J Neurosurg 1967; 26(1): 46-56.
10. Belayev L, Zhao W, Pattany PM, et al. Diffusion-Weighted Magnetic Resonance Imaging Confirms Marked Neuroprotective Efficacy of Albumin Therapy in Focal Cerebral Ischemia. Stroke 1998; 29: 2587-2599
11. th ed. Philadelphia: Butterworth Heinemann 2004; 1197-1243.